These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors. Oz M; Al Kury L; Keun-Hang SY; Mahgoub M; Galadari S Eur J Pharmacol; 2014 May; 731():100-5. PubMed ID: 24642359 [TBL] [Abstract][Full Text] [Related]
25. The evolving role of the endocannabinoid system in gynaecological cancer. Ayakannu T; Taylor AH; Willets JM; Konje JC Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409 [TBL] [Abstract][Full Text] [Related]
26. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948 [TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid system: a general view and latest additions. De Petrocellis L; Cascio MG; Di Marzo V Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801 [TBL] [Abstract][Full Text] [Related]
28. The endocannabinoid system as a target for therapeutic drugs. Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609 [TBL] [Abstract][Full Text] [Related]
29. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098 [TBL] [Abstract][Full Text] [Related]
30. An introduction to the endocannabinoid system: from the early to the latest concepts. De Petrocellis L; Di Marzo V Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257 [TBL] [Abstract][Full Text] [Related]
32. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? Androvicova R; Horacek J; Stark T; Drago F; Micale V Pharmacol Res; 2017 Jan; 115():200-208. PubMed ID: 27884725 [TBL] [Abstract][Full Text] [Related]
33. The complications of promiscuity: endocannabinoid action and metabolism. Alexander SP; Kendall DA Br J Pharmacol; 2007 Nov; 152(5):602-23. PubMed ID: 17876303 [TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptors and endocannabinoids: evidence for new players. Mackie K; Stella N AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380 [TBL] [Abstract][Full Text] [Related]
35. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Giuffrida A; McMahon LR Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530 [TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. Onaivi ES Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083 [TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptors: where they are and what they do. Mackie K J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493 [TBL] [Abstract][Full Text] [Related]
38. The Endocannabinoid System and its Modulation by Phytocannabinoids. Di Marzo V; Piscitelli F Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952 [TBL] [Abstract][Full Text] [Related]
39. The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease. Tanasescu R; Gran B; Constantinescu CS Amino Acids; 2013 Jul; 45(1):95-112. PubMed ID: 22367605 [TBL] [Abstract][Full Text] [Related]